Authors:
Valenta, R
Vrtala, S
Focke-Tejkl, M
Twardosz, A
Swoboda, I
Bugajska-Schretter, A
Spitzauer, S
Kraft, D
Citation: R. Valenta et al., Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy, CL ALLER IM, 16, 2002, pp. 495-517
Authors:
Valenta, R
Twardosz, A
Swoboda, I
Hayek, B
Spitzauer, S
Kraft, D
Citation: R. Valenta et al., Calcium-binding proteins in Type I allergy: Elicitors and vaccines, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, 2000, pp. 365
Authors:
Valenta, R
Vrtala, S
Focke-Tejkl, M
Bugajska-Schretter, A
Ball, T
Twardosz, A
Spitzauer, S
Gronlund, H
Kraft, D
Citation: R. Valenta et al., Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against Type I allergy, BIOL CHEM, 380(7-8), 1999, pp. 815-824
Authors:
Niederberger, V
Hayek, B
Vrtala, S
Laffer, S
Twardosz, A
Vangelista, L
Sperr, WR
Valent, P
Rumpold, H
Kraft, D
Ehrenberger, K
Valenta, R
Spitzauer, S
Citation: V. Niederberger et al., Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7, FASEB J, 13(8), 1999, pp. 843-856
Authors:
Hayek, B
Vangelista, L
Pastore, A
Sperr, WR
Valent, P
Vrtala, S
Niederberger, V
Twardosz, A
Kraft, D
Valenta, R
Citation: B. Hayek et al., Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: Structural basis for calcium-modulated IgE recognition, J IMMUNOL, 161(12), 1998, pp. 7031-7039